Jan-19-2018   15:31 Hrs IST
SPML Infra moves up on its JV bagging order worth Rs 205 crore
+

SPML Infra is currently trading at Rs. 144.20, up by 0.25 points or 0.17% from its previous closing of Rs. 143.95 on the BSE.

The scrip opened at Rs. 145.70 and has touched a high and low of Rs. 147.30 and Rs. 144.10 respectively. So far 17778 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 187.95 on 03-Nov-2017 and a 52 week low of Rs. 48.70 on 27-Jan-2017.

Last one week high and low of the scrip stood at Rs. 162.00 and Rs. 143.00 respectively. The current market cap of the company is Rs. 531.43 crore.

The promoters holding in the company stood at 59.65%, while Institutions and Non-Institutions held 0.40% and 39.95% respectively.

SPML Infra with its joint venture partner OM Metals Infraprojects has secured an international order from Ministry of Food and Agriculture, Republic of Ghana for the work related to rehabilitation and completion of Kpong left bank irrigation project in Ghana, Africa for around Rs 205 crore.

The scope of work includes modification of existing supply canal, main canal, cross regulators and installation of new distribution structures. This World Bank funded project has a time line of 18 months to complete. The Letter of Intent (LoI) received by the JV last week and the projects will be executed within the given period.

SPML Infra is a single source solution provider for various multi disciplinary engineering and infrastructure services from conceptualization to maintenance in water, power, environment and infrastructure projects.

Jan-19-2018   15:16 Hrs IST
IDFC Bank rises despite reporting 24% fall in Q3 net profit
+

IDFC Bank is currently trading at Rs. 58.55, up by 0.35 points or 0.60% from its previous closing of Rs. 58.20 on the BSE.

The scrip opened at Rs. 58.80 and has touched a high and low of Rs. 59.55 and Rs. 57.20 respectively. So far 1930371 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 70.35 on 12-Jan-2018 and a 52 week low of Rs. 51.10 on 18-Dec-2017.

Last one week high and low of the scrip stood at Rs. 69.65 and Rs. 57.20 respectively. The current market cap of the company is Rs. 19770.44 crore.

The promoters holding in the company stood at 52.83%, while Institutions and Non-Institutions held 30.59% and 16.58% respectively.

The Bank has reported 23.61% fall in its net profit at Rs 146.11 crore for third quarter ended December 31, 2017, as compared to Rs 191.26 crore for the same quarter in the previous year. Total income of the Bank decreased by 2.73% at Rs 2514.51 crore for Q3FY18 as compared Rs 2585.08 crore for the corresponding quarter previous year.

The Bank’s gross NPA for the October-December quarter of the current fiscal improved to 5.62%, as compared to 7.03% in the same quarter of the previous year. Besides, Bank’s Net NPA stood at 2.52% in Q3FY18.

Jan-19-2018   15:01 Hrs IST
National Fittings surges on getting nod to amalgamate Interfit India, Merit Industries with itself
+

National Fittings is currently trading at Rs. 230.00, up by 3.50 points or 1.55% from its previous closing of Rs. 226.50 on the BSE.

The scrip opened at Rs. 226.00 and has touched a high and low of Rs. 235.00 and Rs. 225.00 respectively. So far 2292 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 10 has touched a 52 week high of Rs. 285.00 on 09-Aug-2017 and a 52 week low of Rs. 195.00 on 10-Oct-2017.

Last one week high and low of the scrip stood at Rs. 242.00 and Rs. 222.00 respectively. The current market cap of the company is Rs. 188.32 crore.

The promoters holding in the company stood at 65.55%, while Institutions and Non-Institutions held 0.01% and 34.45% respectively.

National Fittings has received an approval for the Scheme of Amalgamation of Interfit India and Merit Industries with itself. The Board of Directors of the company at their meeting held on January 17, 2018, approved the same.

National Fittings is engaged in manufacturing and marketing spheroidal graphite (SG) iron grooved and screwed pipe fittings, stainless pipe fittings and ball valves for industrial and nonindustrial applications.

Jan-19-2018   14:42 Hrs IST
Jubilant FoodWorks trades jubilantly on reporting over 3-fold jump in Q3 net profit
+

Jubilant FoodWorks is currently trading at Rs. 2048.75, up by 107.20 points or 5.52% from its previous closing of Rs. 1941.55 on the BSE.

The scrip opened at Rs. 1950.00 and has touched a high and low of Rs. 2063.25 and Rs. 1945.05 respectively. So far 162848 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2063.25 on 19-Jan-2018 and a 52 week low of Rs. 817.60 on 30-May-2017.

Last one week high and low of the scrip stood at Rs.2063.25 and Rs. 1875.80 respectively. The current market cap of the company is Rs. 13137.52 crore.

The promoters holding in the company stood at 44.94%, while Institutions and Non-Institutions held 43.96% and 10.95% respectively.

Jubilant FoodWorks has reported over 3-fold jump in its net profit at Rs 66.02 crore for the quarter ended December 31, 2017 as compared to net profit of Rs 19.97 crore for the same quarter in the previous year. Total income of the company increased by 20.55% at Rs 798.51 crore for Q3FY18 as compared Rs 662.38 crore for the corresponding quarter previous year.

Jubilant FoodWorks is India’s largest and fastest growing food service company. The company and its subsidiary operates Domino’s Pizza brand with exclusive rights for India, Nepal, Bangladesh and Sri Lanka.

Jan-19-2018   14:16 Hrs IST
Biocon zooms on entering into partnership with Sandoz
+

Biocon is currently trading at Rs. 567.40, up by 27.80 points or 5.15% from its previous closing of Rs. 539.60 on the BSE.

The scrip opened at Rs. 548.00 and has touched a high and low of Rs. 575.30 and Rs. 545.35 respectively. So far 659098 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 575.30 on 19-Jan-2018 and a 52 week low of Rs. 294.71 on 25-May-2017.

Last one week high and low of the scrip stood at Rs. 575.30 and Rs. 525.65 respectively. The current market cap of the company is Rs. 34137.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 20.39% and 18.94% respectively.

Biocon has entered into partnership with Sandoz, a Novartis division and a global leader in biosimilars, to develop, manufacture and commercialize multiple biosimilars in immunology and oncology for patients worldwide.

Under the terms of the agreement, both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products and will have a cost and profit share arrangement globally. Worldwide commercialization responsibilities will be divided and each company's strengths will be leveraged within specific geographies. Sandoz will lead commercialization in North America (US and Canada) and the EU (including European Free Trade Association (EFTA) and Balkan states), while Biocon will lead commercialization in Rest of the World (including India, Russia and Commonwealth of Independent States (CIS)).

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Jan-19-2018   13:59 Hrs IST
Kotak Mahindra Bank gains on reporting 28% rise in Q3 consolidated net profit
+

Kotak Mahindra Bank is currently trading at Rs. 1052.30, up by 6.90 points or 0.66% from its previous closing of Rs. 1045.40 on the BSE.

The scrip opened at Rs. 1053.00 and has touched a high and low of Rs. 1058.50 and Rs. 1043.05 respectively. So far 86215 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1114.35 on 18-Oct-2017 and a 52 week low of Rs. 718.50 on 20-Jan-2017.

Last one week high and low of the scrip stood at Rs. 1058.50 and Rs. 1020.00 respectively. The current market cap of the company is Rs. 200118.42 crore.

The promoters holding in the company stood at 30.06%, while Institutions and Non-Institutions held 48.37% and 21.57% respectively.

Kotak Mahindra Bank has reported rise of 19.72% in its net profit at Rs 1,053.21 crore for the quarter ended December 31, 2017 as compared to Rs 879.76 crore for the same quarter in the previous year. Total income of the Bank increased by 12.48% at Rs 6,049.02 crore for Q3FY18 as compared Rs 5,377.83 crore for the corresponding quarter previous year.

On consolidate basis, the Bank has reported 28.24% rise in its net profit after tax at Rs 1,624.24 crore for the quarter ended December 31, 2017 as compared to Rs 1,266.59 crore for the corresponding quarter in the FY17. Total consolidated income of the Bank increased by 31.86% at Rs 10,113.45 crore for quarter under review as compared to Rs 7,670.04 crore for the same quarter ended previous year.


Jan-19-2018   13:29 Hrs IST
Cadila Healthcare gains after USFDA inspects its API facility at Dabhasa
+

Cadila Healthcare is currently trading at Rs. 443.15, up by 7.05 points or 1.62% from its previous closing of Rs. 436.10 on the BSE.

The scrip opened at Rs. 438.00 and has touched a high and low of Rs. 450.55 and Rs. 433.40 respectively. So far 85,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 558.00 on 12-Jun-2017 and a 52 week low of Rs. 334.35 on 31-Jan-2017.

Last one week high and low of the scrip stood at Rs. 450.95 and Rs. 426.40 respectively. The current market cap of the company is Rs. 45,367.00 crore.

The promoters holding in the company stood at 74.79%, while Institutions and Non-Institutions held 16.93% and 8.28% respectively.

The US Food and Drug Administration (USFDA) has completed an inspection at Cadila Healthcare’s API manufacturing facility at Dabhasa. The facility was inspected in the period from January 15, 2018 to January 19, 2018. At the end of the inspection, no observation (483) was issued.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.


Jan-19-2018   12:56 Hrs IST
L&T trades higher on the bourses
+

Larsen & Toubro (L&T) is currently trading at Rs. 1365.20, up by 6.40 points or 0.47% from its previous closing of Rs. 1358.80 on the BSE.

The scrip opened at Rs. 1361.55 and has touched a high and low of Rs. 1377.70 and Rs. 1355.00 respectively. So far 52899 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1384.35 on 18-Jan-2018 and a 52 week low of Rs. 922.00 on 23-Jan-2017.

Last one week high and low of the scrip stood at Rs. 1384.35 and Rs. 1310.00 respectively. The current market cap of the company is Rs. 191563.05 crore.

The institutions and non-institutions held 57.81% and 42.19% stake in the company, respectively.

L&T’s construction arm -- L&T Construction -- has bagged orders worth Rs 1,310 crore across various business segments.

Under Water & Effluent Treatment Business, the company has won orders worth Rs 631 crore. An order has been secured from Bihar Urban Infrastructure Development Corporation (BUIDCO), Government of Bihar to lay a new sewerage network and construct pumping stations at Saidpur. The scope includes survey, review of designs, redesign and build the new sewerage network of 172 Km length, design & construct 4 pumping stations and all appurtenant structures. Another order has been bagged from Karnataka Neeravari Nigam (KNNL), Government of Karnataka for the execution of a lift irrigation system in Harapanahalli Taluk, Davanagere district.

The company, under Buildings & Factories Business, has secured contract an order worth Rs 340 crore to construct an IT Park at Chennai from a leading developer. The proposed development will offer two towers of ten floors each and is required to be completed within stringent timelines. The company’s scope includes construction of the entire civil structure, architecture works, facade and MEP works.

Under the Power Transmission & Distribution Business, the company has won contract worth Rs 339 crore. The company has secured an order from DNH Power Distribution Corporation for establishing a 66kV Gas Insulated Substation with associated 66kV, 11kV and LT underground cable network in Silvassa city, the capital of the Indian Union Territory of Dadra and Nagar Haveli. The company has also won an order from Bangalore Electricity Supply Company to convert the overhead conductor system to an underground cabling system to achieve reliable and uninterrupted power supply with improved voltage profile, in a subdivision of Bengaluru Metropolitan Area Zone.

Jan-19-2018   12:43 Hrs IST
SREI Infrastructure moves up on getting nod to raise funds in FY19
+

SREI Infrastructure Finance is currently trading at Rs. 99.65, up by 0.05 points or 0.05% from its previous closing of Rs. 99.60 on the BSE.

The scrip opened at Rs. 99.05 and has touched a high and low of Rs. 101.15 and Rs. 98.65 respectively. So far 78379 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 137.70 on 21-Jul-2017 and a 52 week low of Rs. 80.20 on 30-Mar-2017.

Last one week high and low of the scrip stood at Rs. 109.50 and Rs. 98.50 respectively. The current market cap of the company is Rs. 5020.80 crore.

The promoters holding in the company stood at 60.80%, while institutions and non-institutions held 24.27% and 14.93% respectively.

SREI Infrastructure Finance (SREI) has received an approval for public Issue of Redeemable, Non-Convertible Debentures (NCDs) aggregating up to Rs 5,000 crore in one or more tranches during the Financial Year 2018-19. The Board of Directors of the company at their meeting held on January 17, 2018, approved the same.

The Board also approved issue of Redeemable, Non-Convertible Debentures (including Bonds) aggregating up to Rs 5,000 crore outstanding at any point of time during the Financial Year 2018-19 on private placement basis in one or more tranches and issue of Commercial Papers worth Rs 10,000 crore outstanding at any point of time during the Financial Year 2018-19 on private placement basis.

SREI lends for financing infrastructure projects across sectors such as roads, ports, mining and power as well as purchase of infrastructure equipment.

Jan-19-2018   12:30 Hrs IST
Ultratech Cement declines on reporting 23% fall in Q3 consolidated net profit
+

Ultratech Cement is currently trading at Rs. 4333.75, down by 74.80 points or 1.70% from its previous closing of Rs. 4408.55 on the BSE.

The scrip opened at Rs. 4386.90 and has touched a high and low of Rs. 4386.90 and Rs. 4330.00 respectively. So far 5816 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 4594.30 on 16-Jan-2018 and a 52 week low of Rs. 3421.85 on 20-Jan-2017.

Last one week high and low of the scrip stood at Rs. 4594.30 and Rs. 4330.00 respectively. The current market cap of the company is Rs. 119419.09 crore.

The promoters holding in the company stood at 62.05%, while institutions and non-institutions held 27.90% and 9.40% respectively.

Ultratech Cement has reported a fall of 25.19% in its net profit at Rs 421.47 crore for the quarter ended December 31, 2017 as compared to net profit of Rs 563.42 crore for the same quarter in the previous year. However, total income of the company increased by 19.73% at Rs 7745.43 crore for Q3FY18 as compared Rs 6469.21 crore for the corresponding quarter previous year.

On consolidate basis, the company has reported 23.26% fall in its net profit at Rs 456.30 crore for the quarter ended December 31, 2017 as compared to Rs 594.61 crore for the corresponding quarter in the FY17. However, total consolidated income of the company increased by 19.20% at Rs 8175.40 crore for quarter under review as compared to Rs 6858.46 crore for the same quarter in the previous year.

~*46